Je veux savoir à propos de…

29588

Federal Register / Vol. 86, No. 104 / Wednesday, June 2, 2021 / Notices
HRSA specifically requests comments on: 1 The necessity and utility of the proposed information collection for the proper performance of the agencys functions, 2 the accuracy of the estimated burden, 3 ways to enhance the quality, utility, and clarity of the information to be collected, and 4 the use of automated collection techniques or other forms of information technology to minimize the information collection burden.
Maria G. Button, Director, Executive Secretariat.
FR Doc. 202111542 Filed 6121; 8:45 am BILLING CODE 416515P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services Administration Meeting of the Advisory Committee on Infant Mortality Health Resources and Services Administration HRSA, Department of Health and Human Services HHS.
ACTION: Notice.
AGENCY:

In accordance with the Federal Advisory Committee Act, this notice announces that the Advisory Committee on Infant Mortality ACIM
has scheduled a public meeting.
Information about ACIM and the agenda for this meeting can be found on the ACIM website at https www.hrsa.gov/
advisory-committees/infant-mortality/
index.html.
DATES: June 22, 2021, 12:00 p.m.4:00
p.m. Eastern Time ET and June 23, 2021, 12:00 p.m.4:00 p.m. ET.
ADDRESSES: This meeting will be held via webinar. The webinar link and login information will be available at ACIMs website before the meeting:
https www.hrsa.gov/advisorycommittees/infant-mortality/index.html.
FOR FURTHER INFORMATION CONTACT:
Vanessa Lee, MPH, Acting Designated Federal Official, Maternal and Child Health Bureau, HRSA, 5600 Fishers Lane, Rockville, Maryland 20857; 301
4430543; or SACIM@hrsa.gov.
SUPPLEMENTARY INFORMATION: The ACIM
is authorized by section 222 of the Public Health Service Act 42 U.S.C.
217a, as amended. The Committee is governed by provisions of Public Law 92463, as amended, 5 U.S.C. App. 2, which sets forth standards for the formation and use of Advisory Committees.
The ACIM advises the Secretary of HHS on department activities and
jbell on DSKJLSW7X2PROD with NOTICES

SUMMARY:

VerDate Sep<11>2014

17:49 Jun 01, 2021

Jkt 253001

programs directed at reducing infant mortality and improving the health status of pregnant women and infants.
The ACIM represents a public-private partnership at the highest level to provide guidance and focus attention on the policies and resources required to address the reduction of infant mortality and the improvement of the health status of pregnant women and infants.
With a focus on life course, the ACIM
addresses disparities in maternal health to improve maternal health outcomes, including preventing and reducing maternal mortality and severe maternal morbidity. The ACIM provides advice on how best to coordinate myriad federal, state, local, and private programs and efforts that are designed to deal with the health and social problems impacting infant mortality and maternal health, including implementation of the Healthy Start program and maternal and infant health objectives from the National Health Promotion and Disease Prevention Objectives i.e., Healthy People 2030.
The agenda for the June 2223, 2021, meeting is being finalized and may include the following topics: Discussion of recommendations by ACIM to the Secretary; updates from HRSAs Maternal and Child Health Bureau, and other federal agencies; the Centers for Disease Control and Preventions Pregnancy Risk Assessment Monitoring System survey; and patient-physician racial concordance in health care.
Agenda items are subject to change as priorities dictate. Refer to the ACIM
website for any updated information concerning the meeting.
Members of the public will have the opportunity to provide written or oral comments. Requests to submit a written statement or make oral comments to the ACIM should be sent to Vanessa Lee, using the email address above at least 3
business days prior to the meeting.
Public participants may submit written statements in advance of the scheduled meeting by emailing SACIM@hrsa.gov.
Oral comments will be honored in the order they are requested and may be limited as time allows.
Individuals who plan to attend and need special assistance or another reasonable accommodation should notify Vanessa Lee at the contact information listed above at least 10
business days prior to the meeting.
Maria G. Button, Director, Executive Secretariat.
FR Doc. 202111504 Filed 6121; 8:45 am BILLING CODE 416515P

PO 00000

Frm 00043

Fmt 4703

Sfmt 4703

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health.
National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; Music and Health.
Date: June 24, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 Virtual Meeting.
Contact Person: W. Ernest Lyons, PhD, Scientific Review Administrator, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3208, MSC 9529, Rockville, MD 20852, 3014964056, lyonse@ninds.nih.gov.
Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; Small Vessel VCID
Biomarkers Validation Consortium Sites &
Coordinating Center Review U01 & U24.
Date: June 25, 2021.
Time: 10:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 Virtual Meeting.
Contact Person: Mir Ahamed Hossain, PhD, Scientific Review Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3208, MSC 9529, Rockville, MD 20852, 3014969223, mirahamed.hossain@nih.gov.
Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS

E:FRFM02JNN1.SGM

02JNN1